Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice

Clinical and Experimental Immunology

Volumn 116, Issue 2, 1999, Pages 225-230

  Hartemann, A H ^a   Richard, M F ^a   Boitard, Christian ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Islet infiltrate; NOD mice; Th2 cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DESTRUCTION; CELL INFILTRATION; CYTOKINE RELEASE; DIABETES MELLITUS; FEMALE; HELPER CELL; IMMUNE RESPONSE; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; TH2 CELLS;

EID: 0032941174     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00883.x     Document Type: Article

References (36)

1. 1 Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35:855-60.
2. 2 Bendelac A, Camaud C, Boitard C et al. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 1987; 166:823-32.
3. 3 Miller BJ, Appel MC, O'Neil JJ et al. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988; 140:52-8.
4. 4 Charlton B, Bacelj A, Slattery RM et al. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus. Diabetes 1989; 38:441-7.
5. 5 Dardenne M, Lepault F, Bendelac A et al. Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur J Immunol 1989; 19:889-95.
6. 6 Boitard C, Yasunami R, Dardenne M et al. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169:1669-80.
7. 7 Chosich N, Harrison LC. Suppression of diabetes mellitus in the nonobese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Diabetologia 1993; 36:716-21.
8. 8 Scott B, Liblau R, Degermann S et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1994; 1:73-83.
9. 9 Sarvetnick N, Shizuru J, Liggitt D et al. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990; 30:844-7.
10. 10 Lee MS, von Herrath M, Reiser H et al. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. J Clin Invest 1995; 95:486-92.
11. 11 Haskins K, McDuffie M. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990; 21: 1433-6.
12. 12 Healey D, Ozegbe P, Arden S et al. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest 1995; 95:2979-85.
13. 13 Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes 1996; 45:1299-305.
14. 14 Debray-Sachs M, Carnaud C, Boitard C et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 1991; 4:237-48.
15. 15 Campbell IL, Kay TW, Oxbrow L et al. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wchi mice. J Clin Invest 1991; 87:739-42.
16. 16 Shehadeh NN, La Rosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6:291-300.
17. 17 Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178:87-99.
18. 18 Skidmore BJ, Stamnes SA, Townsend K et al. Enumeration of cytokine-secreting cells at the single-cell level. Eur J Immunol 1989; 19:1591-7.
19. 19 Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5 using modified cDNA expression vectors. Eur J Immunol 1988; 18:98-104.
20. 20 Lacy PE, Kostianovsky M. A method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16:35-39.
21. 21 Christianson SW, Shultz LD, Leiter EM. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993; 42:44-55.
22. 22 Liblau RS, Singer SM, McDevitt HO. Th1 and Th2, CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 16:34-38.
23. 23 Rothe H, Jenkins NA, Copeland NG et al. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 1997; 99:469-74.
24. 24 Haskins K, Portas M, Bergman B et al. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA 1989; 86:8000-4.
25. 25 Daniel D, Gill RG, Schloot N et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995; 25:1056-62.
26. 26 Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1995; 26:1185-8.
27. 27 Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72.
28. 28 Tisch R, Yang XD, Liblau RS et al. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J Autoimmun 1994; 7:845-50.
29. 29 Tian BJ, Lehmann PV, Kaufman D, Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med 1997; 186:2039-3043.
30. 30 Tian BJ, Atkinson MA, Clare-Slalzer M et al. Nasal administration of glutamate decarboxylase (GAD 65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 1996; 183:1561-7.
31. 31 Tian J, Clare-Salzler M, Herschenfeld A et al. Modulating autoimmune response to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature Medecine 1996; 12:1348-53.
32. 32 Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J Exp Med 1994; 179:1379-84.
33. 33 Anderson JT, Cornelius JG, Jarpe AJ et al. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity 1993; 15:113-21.
34. 34 Rohane PW, Shimada A, Kim DT et al. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice. Diabetes 1995; 44:550-4.
35. 35 Rabinovitch A, Suarez-Pinzon WL, Sorensen O et al. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 1995; 154:4874-82.
36. 36 Yagi H, Matsumoto M, Kunimoto K et al. Analysis of the roles of CD4+ and CD8+ T cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 1992; 22:2387-93.